World's Largest Resource for Cardiovascular Perfusion

+1 888-499-5672 Login

Twenty Years of Vasoplegic Syndrome Treatment in Heart Surgery. Methylene Blue Revised

Main Zone, Mobile Zone, Perfusion Zone

1 min read

Objective: This study was conducted to reassess the concepts established over the past 20 years, in particular in the last 5 years, about the use of methylene blue in the treatment of vasoplegic syndrome in cardiac surgery.

Methods: A wide literature review was carried out using the data extracted from: MEDLINE, SCOPUS and ISI WEB OF SCIENCE.

Results: The reassessed and reaffirmed concepts were 1) MB is safe in the recommended doses (the lethal dose is 40 mg/kg); 2) MB does not cause endothelial dysfunction; 3) The MB effect appears in cases of NO up-regulation; 4) MB is not a vasoconstrictor, by blocking the cGMP pathway it releases the cAMP pathway, facilitating the norepinephrine vasoconstrictor effect; 5) The most used dosage is 2 mg/kg as IV bolus, followed by the same continuous infusion because plasma concentrations sharply decrease in the first 40 minutes; and 6) There is a possible “window of opportunity” for MB’s effectiveness. In the last five years, major challenges were: 1) Observations about side effects; 2) The need for prophylactic and therapeutic guidelines, and; 3) The need for the establishment of the MB therapeutic window in humans.

Conclusion: MB action to treat vasoplegic syndrome is time-dependent. Therefore, the great challenge is the need, for the establishment the MB therapeutic window in humans. This would be the first step towards a systematic guideline to be followed by possible multicenter studies.

Epic Staffing

You may also like

Perfusion Zone, Tiny Perfusion Letter

Should Zero Harm Be Our Goal?

The purpose of this Surgical Perspectives is to explore the conflicts associated with “Aiming at Zero,” and to propose an alternative paradigm.

1 min read

Biologics Zone, Blood Management, Main Zone, Mobile Zone

Dual Effect of Platelet Lysate on Human Articular Cartilage: A Maintenance of Chondrogenic Potential and a Transient Proinflammatory Activity Followed by an Inflammation Resolution

Our findings support the concept that the platelet products have a direct beneficial effect on articular chondrocytes and could drive in sequence a transient activation and the resolution of the inflammatory process, thus providing a rational for their use as therapeutic agents in cartilage inflammation and damage.

1 min read

Blood Management, Main Zone, Mobile Zone, Perfusion Zone

The Operating Surgeon Is an Independent Predictor of Chest Tube Drainage Following Cardiac Surgery

Bleeding into the chest is a major cause of blood transfusion and adverse outcomes following cardiac surgery. The authors investigated predictors of bleeding following cardiac surgery to identify potentially correctable factors.

1 min read